6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Neural Correlates of Drug Craving
Drug craving is a key feature of addiction, driven by complex neural mechanisms involving reward and memory circuits. The mesolimbic dopamine pathway, particularly the nucleus accumbens, plays a central role in craving by reinforcing substance-related cues. The prefrontal cortex, responsible for decision-making and impulse control, often exhibits impaired functioning, making it difficult for individuals to resist urges. Additionally, the amygdala and hippocampus contribute by linking emotional and contextual triggers to past substance use experiences. Neuroimaging studies have revealed heightened activity in these brain regions during craving episodes, highlighting potential targets for interventions like transcranial magnetic stimulation (TMS) and pharmacotherapy to reduce craving intensity.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Malasri Chaudhery Malgeri
Recovery com, United States
Jana Furstova
Palacký University Olomouc, Czech RepublicSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States